These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 18221133)
21. Novel approaches to flavivirus drug discovery. Botting C; Kuhn RJ Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769 [TBL] [Abstract][Full Text] [Related]
22. DNA vaccines for flaviviruses. Putnak R; Porter K; Schmaljohn C Adv Virus Res; 2003; 61():445-68. PubMed ID: 14714440 [No Abstract] [Full Text] [Related]
23. Subgenomic flavivirus RNA as key target for live-attenuated vaccine development. Doets K; Pijlman GP J Virol; 2024 Jul; 98(7):e0010023. PubMed ID: 38808973 [TBL] [Abstract][Full Text] [Related]
24. Strategies for the identification of inhibitors of West Nile virus and other flaviviruses. Shi PY Curr Opin Investig Drugs; 2002 Nov; 3(11):1567-73. PubMed ID: 12476954 [TBL] [Abstract][Full Text] [Related]
25. Strategies Towards Protease Inhibitors for Emerging Flaviviruses. Nitsche C Adv Exp Med Biol; 2018; 1062():175-186. PubMed ID: 29845533 [TBL] [Abstract][Full Text] [Related]
27. Progress and Works in Progress: Update on Flavivirus Vaccine Development. Collins MH; Metz SW Clin Ther; 2017 Aug; 39(8):1519-1536. PubMed ID: 28754189 [TBL] [Abstract][Full Text] [Related]
28. A Perspective on Current Flavivirus Vaccine Development: A Brief Review. Dutta SK; Langenburg T Viruses; 2023 Mar; 15(4):. PubMed ID: 37112840 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein. de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406 [TBL] [Abstract][Full Text] [Related]
30. Flavivirus DNA vaccines: current status and potential. Chang GJ; Davis BS; Hunt AR; Holmes DA; Kuno G Ann N Y Acad Sci; 2001 Dec; 951():272-85. PubMed ID: 11797784 [TBL] [Abstract][Full Text] [Related]
31. Inhibitors compounds of the flavivirus replication process. García LL; Padilla L; Castaño JC Virol J; 2017 May; 14(1):95. PubMed ID: 28506240 [TBL] [Abstract][Full Text] [Related]
33. Antiviral Activity of Benzavir-2 against Emerging Flaviviruses. Gwon YD; Strand M; Lindqvist R; Nilsson E; Saleeb M; Elofsson M; Överby AK; Evander M Viruses; 2020 Mar; 12(3):. PubMed ID: 32235763 [TBL] [Abstract][Full Text] [Related]
34. Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo. Li PC; Jang J; Hsia CY; Groomes PV; Lian W; de Wispelaere M; Pitts JD; Wang J; Kwiatkowski N; Gray NS; Yang PL ACS Infect Dis; 2019 Mar; 5(3):460-472. PubMed ID: 30608640 [TBL] [Abstract][Full Text] [Related]
35. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700 [TBL] [Abstract][Full Text] [Related]
36. Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses. Dhalia R; Maciel M; Cruz FS; Viana IF; Palma ML; August T; Marques ET An Acad Bras Cienc; 2009 Dec; 81(4):663-9. PubMed ID: 19893892 [TBL] [Abstract][Full Text] [Related]
37. Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View. Felicetti T; Manfroni G; Cecchetti V; Cannalire R ChemMedChem; 2020 Dec; 15(24):2391-2419. PubMed ID: 32961008 [TBL] [Abstract][Full Text] [Related]
38. The flavivirus capsid protein: Structure, function and perspectives towards drug design. Oliveira ERA; Mohana-Borges R; de Alencastro RB; Horta BAC Virus Res; 2017 Jan; 227():115-123. PubMed ID: 27751882 [TBL] [Abstract][Full Text] [Related]
39. Mouse and hamster models for the study of therapy against flavivirus infections. Charlier N; De Clercq E; Neyts J Novartis Found Symp; 2006; 277():218-29; discussion 229-32, 251-3. PubMed ID: 17319165 [TBL] [Abstract][Full Text] [Related]
40. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. Chávez JH; Silva JR; Amarilla AA; Moraes Figueiredo LT Biologicals; 2010 Nov; 38(6):613-8. PubMed ID: 20817489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]